Top cardiology stories: FDA panel supports implantable pulse generator, myocardial strain increases with long distance running

Among the most-read stories in cardiology this past week were the vote by the Circulatory Systems Device Panel of the FDA in support of the premarket approval of an implantable pulse generator to manage patients with heart failure and data suggesting that myocardial strain increases with longer races for amateur runners.

Other top stories included studies indicating that aggressive intervention improves glycemic control among non-adherent patients with diabetes, direct oral anticoagulant use is lower in patients with a higher CHA2DS2-VASc score and variations in time delays are prominent among remote monitoring systems in implantable cardioverter defibrillators.

FDA panel supports premarket approval of implantable pulse generator for heart failure

The Circulatory Systems Device Panel of the FDA voted 12-1 and 11-2, respectively, in favor of the safety and efficacy of an implantable pulse generator, based on available data, to support a premarket approval application for use in patients with heart failure. Read more.

Myocardial strain increases with longer races for amateur runners

Amateur runners competing in full marathons had more strain on the myocardium compared with those who ran half marathons and 10-km races, according to a study published in Circulation. Read more.

Aggressive intervention improves glycemic control among non-adherent patients with diabetes

CHICAGO — Aggressive intervention with insulin in patients with type 2 diabetes who were at risk for being non-adherent resulted in improved glycemic control despite not affecting treatment persistence, according to research presented during the American Heart Association Scientific Sessions. Read more.

Direct oral anticoagulant use lower with higher CHA2DS2-VASc score

CHICAGO — New data presented at the American Heart Association Scientific Sessions suggest that in a real-world setting, use of direct oral anticoagulants was lower than warfarin in patients with a high CHA2DS2-VASc score. Read more.

Variations in time delays prominent among remote monitoring systems in implantable cardioverter defibrillators

Among implantable cardioverter defibrillators with remote monitoring systems, there are significant differences in time delay from event detection to acknowledgement by hospital staff, according to a study published in HeartRhythm. Read more.

Among the most-read stories in cardiology this past week were the vote by the Circulatory Systems Device Panel of the FDA in support of the premarket approval of an implantable pulse generator to manage patients with heart failure and data suggesting that myocardial strain increases with longer races for amateur runners.

Other top stories included studies indicating that aggressive intervention improves glycemic control among non-adherent patients with diabetes, direct oral anticoagulant use is lower in patients with a higher CHA2DS2-VASc score and variations in time delays are prominent among remote monitoring systems in implantable cardioverter defibrillators.

FDA panel supports premarket approval of implantable pulse generator for heart failure

The Circulatory Systems Device Panel of the FDA voted 12-1 and 11-2, respectively, in favor of the safety and efficacy of an implantable pulse generator, based on available data, to support a premarket approval application for use in patients with heart failure. Read more.

Myocardial strain increases with longer races for amateur runners

Amateur runners competing in full marathons had more strain on the myocardium compared with those who ran half marathons and 10-km races, according to a study published in Circulation. Read more.

Aggressive intervention improves glycemic control among non-adherent patients with diabetes

CHICAGO — Aggressive intervention with insulin in patients with type 2 diabetes who were at risk for being non-adherent resulted in improved glycemic control despite not affecting treatment persistence, according to research presented during the American Heart Association Scientific Sessions. Read more.

Direct oral anticoagulant use lower with higher CHA2DS2-VASc score

CHICAGO — New data presented at the American Heart Association Scientific Sessions suggest that in a real-world setting, use of direct oral anticoagulants was lower than warfarin in patients with a high CHA2DS2-VASc score. Read more.

Variations in time delays prominent among remote monitoring systems in implantable cardioverter defibrillators

Among implantable cardioverter defibrillators with remote monitoring systems, there are significant differences in time delay from event detection to acknowledgement by hospital staff, according to a study published in HeartRhythm. Read more.